How has been the historical performance of Venus Remedies?

Answer:The historical performance of Venus Remedies shows a trend of increasing net sales and profits over the years, with significant fluctuations in certain metrics. Breakdown: Venus Remedies has demonstrated a consistent growth in net sales, rising from 321.89 crore in March 2019 to 647.89 crore in March 2025. The total operating income followed a similar trajectory, reaching 647.89 crore in March 2025, up from 555.51 crore in March 2023. The company's operating profit (PBDIT) also increased, peaking at 84.50 crore in March 2025, while profit before tax surged to 71.83 crore in the same period, compared to a loss of 29.73 crore in March 2019. Profit after tax reached 45.32 crore in March 2025, reflecting a recovery from previous years of losses, including a significant loss of 10.00 crore in March 2020. The company's earnings per share (EPS) improved to 33.9 in March 2025, up from a negative EPS of -23.16 in March 2019. On the balance sheet, total assets increased to 715.72 crore in March 2025, while total liabilities rose to 715.72 crore, indicating a balanced growth. Cash flow from operating activities showed a positive trend, with a net cash inflow of 27.00 crore in March 2024, following a negative cash flow in previous years. Overall, Venus Remedies has shown resilience and growth in its financial performance over the years.